Genistein: Does it prevent or promote breast cancer?

Environmental Health Perspectives

Volumn 108, Issue 8, 2000, Pages 701-708

  Bouker, Kerrie B ^a   Hilakivi Clarke, Leena ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Antiproliferative effects; Breast cancer; Estrogenic effects; Genistein

Indexed keywords

ANTIESTROGEN; GENISTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ASIAN; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DIET; ESTROGEN ACTIVITY; FEMALE; FOOD INTAKE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SOYBEAN; TUMOR PROMOTION;

ANIMALIA; GLYCINE MAX;

EID: 0033789914     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108701     Document Type: Review

References (108)

1. Cancer epidemiology in populations of the United States - With emphasis on Hawaii, California and Japan
2. Cancer in first and second generation Americans
3. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles county
4. Migration patterns and breast cancer risk in Asian-American women
5. The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women
6. Sex hormones in women in rural China and Britain
7. The lessons of life: Keynote address to the nutrition and cancer conference
8. Diet, nutrition, and avoidable cancer
9. Soy intake and breast cancer: A review of the in vitro and in vivo data
10. Genistein, a specific inhibitor of tyrosine-specific protein kinase
11. Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints
12. Genistein, a dietary-derived inhibitor of in vitro angiogenesis
13. Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines
14. Evolution, nutrition, intestinal microflora, and prevention of cancer: A hypothesis
15. Inhibition of CYP1A1 enzyme activity in mouse hepatoma cell culture by soybean isoflavones
16. Phytoestrogens and breast cancer
17. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo
18. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro
19. Molecular effects of genistein on estrogen receptor mediated pathways
20. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats
21. Maternal exposure to genistein mimics the effects of estradiol on mammary gland development among female mouse offspring
22. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women
23. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast
24. The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency
25. Phytoestrogens: Adverse effects on reproduction in California quail
26. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model
27. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance
28. Thrombotic mechanisms in atherosclerosis: Potential impact of soy proteins
29. Phytoestrogen interaction with estrogen receptors in human breast cancer cells
30. Stimulation of pS2 expression by diet-derived compounds
31. Differentiation between vasoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta
32. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency
33. Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats
34. Effects of soya consumption for one month on steroid hormones in premenopausal women: Implications for breast cancer risk reduction
35. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women
36. Breast cancer: Cause and prevention
37. Search for a killer: Focus shifts from fat to hormones
38. A prospective study of endogenous estrogens and breast cancer in postmenopausal women
39. Growth factors in breast cancer
40. The risk of breast cancer following reproductive surgery
41. Tamoxifen treatment for breast cancer: Concept to gold standard
42. Genistein stimulated proliferation of human breast cancer cells
43. Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats
44. Inhibition of 17-beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells
45. Human 17-beta-hydroxysteroid dehydrogenase type 1 and 2 isoenzyme have opposite activities in cultured cells and characteristic cell- and tissue-specific expression
46. Role of 17-beta-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol synthesis
47. Lignans and isoflavonoids inhibit aromatase enzyme in human preadipocytes
48. Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women
49. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women
50. Biological effects of isoflavones in young women: Importance of the chemical composition of soybean products
51. Soy isoflavones exert modest hormonal effects in premenopausal women
52. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women
53. Acute and subacute effects of naturally occurring estrogens on luteinizing hormone secretion in the ovariectomized rat: Part 1
54. Regulation of sex hormone-binding globulin production by isoflavonoids and patterns of isoflavonoid conjugation in HepG2 cell cultures
55. Flavonoids inhibit estrogen binding to rat alpha-fetoprotein
56. Steroid and phyto-estrogen binding to sheep uterine receptors in vitro
57. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
58. Differential ligand activation of estrogen receptors ER alpha and ER beta at AP1 sites
59. Genistein suppresses mammary cancer in rats
60. Soy intake and risk of breast cancer in Asians and Asian Americans
61. Dietary effects on breast cancer risk in Singapore
62. The chemopreventive properties of soy isoflavonoids in animal models of breast cancer
63. Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A
64. Dietary soybean isolate and metholonine supplementation affects mammary tumor progression in rats
65. Genistein exerts multiple suppressive effects on human breast carcinoma cells
66. Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid
67. Factors associated obtaining nipple aspirate fluid: Analysis of 1428 women and literature review
68. Cerumen phenotype and proliferative epithelium in breast fluids of U.S.-born vs. immigrant Asian women: A possible genetic-environment interaction
69. Mitogenic growth factors in breast fluid obtained from healthy women: Evaluation of biological and extragenous sources of variability
70. Tofu and risk of breast cancer in Asian-Americans
71. Case-control study of phytoestrogens and breast cancer
72. Urinary excretion of isoflavonoids and the risk of breast cancer
73. Occurrence of breast cancer in relation to diet and reproductive history: A case-control study in Fukuoka, Japan
74. Diet and premenopausal bilateral breast cancer: A case-control study
75. Diet and breast cancer in Shanghai and Tianjin, China
76. Meta-analysis of soy intake and breast cancer risk
77. Antiestrogens are partial estrogen agonists for prolactin production in primary pituitary cultures
78. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis
79. Inhibition of protein tyrosine phosphorylation in endothelial cells: Relationship to antiproliferative action of genistein
80. Genistein arrests cell cycle progression
81. Mechanisms of action of the soy isoflavone genistein: Emerging role for its effects via transforming growth factor beta signaling pathways
82. EGF receptor expression, regulation, and function in breast cancer
83. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells
84. Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells
85. Cytotoxic activity of epidermal growth factor-genistein against human breast cancer cells
86. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases
87. Tyrosine phosphorylation of membrane proteins mediated cellular invasion by transformed cells
88. Effects of dietary menhaden oil, soy, and a cyclooxygenase inhibitor on human breast cancer cell growth and metastasis in nude mice
89. Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein
90. Timing of dietary fat exposure and mammary tumorigenesis: Role of estrogen receptor and protein kinase C activity
91. Maternal exposure to genistein during pregnancy increases mammary tumorigenesis in female rat off-spring
92. Effects of perinatal exposure to a synthetic estrogen and progestin on mammary tumorigenesis in mice
93. Estrogen-associated defects in rodent mammary gland development
94. Premenopausal breast cancer after in utero exposure to stilbestrol
95. Birthweight as a risk factor for breast cancer
96. Intrauterine environment and breast cancer risk in women: A population-based study
97. The effective free fraction of estradiol xenoestrogens in human serum measured by whole cell uptake assays: Physiology of delivery modifies estrogenic activity
98. Maternal and neonatal phytoestrogens in Japanese women during birth
99. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats
100. Prepubertal genistein treatment modulates TGF-alpha, EGF and EGF-receptor mRNAs and proteins in the rat mammary gland
101. Dietary genistein: Perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat
102. Effect of neonatally administered estrogen and prolactin on normal and neoplastic mammary growth and serum estradiol-17 level in rats
103. Chemoprevention of N-nitro-N-methylurea-induced mammary cancers by pretreatment with 17beta-estradiol and progesterone
104. Body size at different periods of life and breast cancer risk
105. Body size in different periods of life and breast cancer risk in post-menopausal women